STAT

Opinion: Sexually transmitted infections are at an all-time high. Urgent action is needed

Clinicians and public health experts know how to prevent STIs. But the country has failed to implement basic public health practices to do that.
A billboard from the AIDS Healthcare Foundation warning of drug-resistant gonorrhea is seen on Sunset Boulevard in Hollywood, Calif. Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the U.S. in 2017.

The Centers for Disease Control and Prevention reported Tuesday unprecedented year-after-year rises in rates of sexually transmitted infections (STIs) in the United States. As physicians who care for patients with these infections and who oversee public health responses to STI outbreaks, we, like many of our colleagues, are frustrated and challenged by the anemic responses to this escalating public health epidemic.

Our concerns are especially acute because the medical and public health communities know how to prevent these infections, yet as a country we have failed to implement basic public health practices that could reverse these trends.

STIs are at an . Nearly 2.3 million cases of chlamydia, — infants born with syphilis contracted from their undiagnosed and untreated mothers — more than doubled from 2013 to 2017. Congenital syphilis is especially worrisome because it can cause miscarriage, premature birth, stillbirth, or death of newborn babies.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks